Australia markets close in 1 hour 46 minutes

Fujian Aonong Biological Technology Group Incorporation Limited (603363.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
3.5700-0.0600 (-1.65%)
As of 11:30AM CST. Market open.
Currency in CNY

Valuation measures4

Market cap (intra-day) 3.16B
Enterprise value 11.50B
Trailing P/E 10.07
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.15
Price/book (mrq)2.97
Enterprise value/revenue 0.54
Enterprise value/EBITDA -7.41

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-63.26%
S&P500 52-week change 321.08%
52-week high 310.0900
52-week low 32.3800
50-day moving average 34.2892
200-day moving average 36.9578

Share statistics

Avg vol (3-month) 354.38M
Avg vol (10-day) 335.15M
Shares outstanding 5870.28M
Implied shares outstanding 6882.26M
Float 8448.73M
% held by insiders 152.94%
% held by institutions 11.55%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 408 June 2021
Last split factor 21.3:1
Last split date 321 Oct 2020

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin -8.21%
Operating margin (ttm)-6.11%

Management effectiveness

Return on assets (ttm)-4.94%
Return on equity (ttm)-70.90%

Income statement

Revenue (ttm)21.39B
Revenue per share (ttm)24.88
Quarterly revenue growth (yoy)-22.40%
Gross profit (ttm)N/A
EBITDA -412.58M
Net income avi to common (ttm)-1.76B
Diluted EPS (ttm)-2.0700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)303.49M
Total cash per share (mrq)0.35
Total debt (mrq)8.64B
Total debt/equity (mrq)493.42%
Current ratio (mrq)0.36
Book value per share (mrq)1.24

Cash flow statement

Operating cash flow (ttm)1.31B
Levered free cash flow (ttm)577.87M